NET G3 vs NEC: p53 and Rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential Diagnosis?
Journal of Gastrointestinal and Liver Diseases · 2023
DOI: 10.15403/jgld-4654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2023. Verfasst von Alexandra Dinu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Service of Pathology, Sf. Apostol Andrei Emergency County Hospital, Constanta, Romania. . amaiorean@yahoo.co.uk. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, Gastrointestinal Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims: High-grade gastrointestinal neuroendocrine neoplasms (GI-NENs) are divided into well-differentiated G3 neuroendocrine tumors (NETs G3) and neuroendocrine carcinomas (NECs), having identical cut-offs of proliferation, but different biomolecular origins. This translates in distinct treatment choices. Our aim was to establish if p53/Rb1 immunohistochemical status in GI-NENs with Ki67 index >20% can predict the histopathological diagnosis. Methods: p53/Rb1 immunolabelling was performed on 42 cases of high-grade GI-NENs, diagnosed as NET G3, NEC and mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) with NEC component. Immunolabeled slides were digitally scanned, with automatic quantification of p53 and Rb1, blind to the diagnosis. Results: The p53 positive percentage was stratified; two cut-offs were selected, naming the intervals as N (null, 20%). The Rb1 expression loss in >90% of neoplastic cells was considered mutational. NETs G3 mainly showed the T status (14/16, 87.5%), followed by N (1/16, 6.25%) and C (1/16, 6.25%); NECs and NEC components in MiNENs predominantly expressed the C status (19/26, 73.08%), followed by N (5/26, 19.23%) and T (2/26, 7.69%) (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Service of Pathology, Sf. Apostol Andrei Emergency County Hospital, Constanta, Romania. . amaiorean@yahoo.co.uk.
- Clinical Service of Pathology, Sf. Apostol Andrei Emergency County Hospital, Constanta; Medicine Faculty, Ovidius University of Constanta, Constanta; Center for Research and Development of the Morphological and Genetic…
- Clinical Service of Pathology, Sf. Apostol Andrei Emergency County Hospital, Constanta; Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology, Ovidius University of Constant…
- Medicine Faculty, Ovidius University of Constanta, Constanta; Surgery Department, Sf. Apostol Andrei Emergency County Hospital, Constanta, Romania. catalin.grasa@yahoo.com.
- Medicine Faculty, Ovidius University of Constanta, Constanta; Surgery Department, Sf. Apostol Andrei Emergency County Hospital, Constanta, Romania. eduardiordache@yahoo.com.
- Clinical Service of Pathology, Sf. Apostol Andrei Emergency County Hospital, Constanta; Medicine Faculty, Ovidius University of Constanta, Constanta, Romania. deacu_mariana@yahoo.com.
Zitieren
APA
Dinu, A., Aschie, M., Cozaru, G. C., Mitroi, A. F., Grasa, C. N., Iordache, I. E., Deacu, M., Orasanu, C. I., Nicolau, A. A., & Baltatescu, G. I. (2023). NET G3 vs NEC: p53 and Rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential Diagnosis?. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-4654
Vancouver
Dinu A, Aschie M, Cozaru GC, Mitroi AF, Grasa CN, Iordache IE, et al. NET G3 vs NEC: p53 and Rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential Diagnosis?. Journal of Gastrointestinal and Liver Diseases. 2023. doi:10.15403/jgld-4654
BibTeX
@article{Dinu2023,
author = {Dinu, Alexandra and Aschie, Mariana and Cozaru, Georgeta Camelia and Mitroi, Anca Florentina and Grasa, Catalin Nicolae and Iordache, Ionut Eduard and Deacu, Mariana and Orasanu, Cristian Ionut and Nicolau, Antonela-Anca and Baltatescu, Gabriela Izabela},
title = {NET G3 vs NEC: p53 and Rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential Diagnosis?},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2023},
doi = {10.15403/jgld-4654}
}
EUVIMED